Skip to main content

Table 2 c-erbB-2 score evaluations

From: The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas

  

c-erbB-2 score

 
  

Negative

n (%)

Positive

n (%)

P†

Menstrual Status

Premenopausal

16 (72,7)

6 (27,3)

 
 

Postmenopausal

43 (86)

7 (14)

0,177

Histological Grade

Grade 1

22 (88)

3 (12)

0,484

 

Grade 2

30 (76,9)

9 (23,1)

 
 

Grade 3

7 (87,5)

1 (12,5)

 

Invasion Depth

<1/2

31 (75,6)

10 (24,4)

0,243

 

>1/2

23 (92)

2 (8)

 
 

Limited to endometrium

5 (83,3)

1 (16,7)

 

Lymph Node Status

Positive

3 (75)

1 (25)

0,615

 

Negative

28 (93,3)

2 (6,7)

 

Stage

I

26 (92,9)

2 (7,1)

 
 

II

1 (100)

0 (0)

 
 

III

4 (80)

1 (20)

 

Estrogen

Positive

52 (85,2)

9 (14,8)

0,086

 

Negative

7 (63,6)

4 (36,4)

 

Progesterone

Positive

51 (86,4)

8 (13,6)

0,035

 

Negative

8 (61,5)

5 (38,5)

 

Survival

Alive

36 (81,82)

8 (18,18)

0,215

 

Death

5 (100)

0 (0)

 
  1. †: Chi square test. p < 0,05 significant; p > 0,005 insignificant